Cargando…

Celecoxib Ameliorates Non-Alcoholic Steatohepatitis in Type 2 Diabetic Rats via Suppression of the Non-Canonical Wnt Signaling Pathway Expression

Our aim was to test whether pharmacological inhibition of cycloxygenase-2 (COX-2) reverses non-alcoholic steatohepatitis (NASH) in type 2 diabetes mellitus (T2DM) rats via suppression of the non-canonical Wnt signaling pathway expression. Twenty-four male Sprague-Dawley rats were randomly distribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, Feng, Zhang, Ya Jie, Li, Yu, Xie, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880264/ https://www.ncbi.nlm.nih.gov/pubmed/24404139 http://dx.doi.org/10.1371/journal.pone.0083819

Ejemplares similares

Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats
por: Zhu, Guoying, et al.
Publicado: (2022)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Wnt Signaling Upregulates Teneurin-3 Expression via Canonical and Non-canonical Wnt Pathway Crosstalk
por: Bastías-Candia, Sussy, et al.
Publicado: (2019)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond, Ehud, et al.
Publicado: (2014)

Dual modulation of human hepatic zonation via canonical and non-canonical Wnt pathways
por: McEnerney, Laura, et al.
Publicado: (2017)

Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors
por: Colli, Leandro Machado, et al.
Publicado: (2013)

Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases
por: Ackers, Ian, et al.
Publicado: (2017)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020)

GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
por: Kim, Hyeon Ju, et al.
Publicado: (2020)

Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling
por: Sheng, Ren, et al.
Publicado: (2014)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

The phytochemical polydatin ameliorates non‐alcoholic steatohepatitis by restoring lysosomal function and autophagic flux
por: Chen, Xiaoting, et al.
Publicado: (2019)

Artemether Ameliorates Non-Alcoholic Steatohepatitis by Repressing Lipogenesis, Inflammation, and Fibrosis in Mice
por: Xu, Jia, et al.
Publicado: (2022)

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
por: Yu, Amy, et al.
Publicado: (2022)

Roles of Non-Canonical Wnt Signalling Pathways in Bone Biology
por: Lojk, Jasna, et al.
Publicado: (2021)

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Exogenous H(2)S mitigates myocardial fibrosis in diabetic rats through suppression of the canonical Wnt pathway
por: Yang, Rui, et al.
Publicado: (2019)

Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis
por: Wang, Wei, et al.
Publicado: (2013)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Ruscogenin Ameliorates Experimental Nonalcoholic Steatohepatitis via Suppressing Lipogenesis and Inflammatory Pathway
por: Lu, Hung-Jen, et al.
Publicado: (2014)

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
por: Park, Jung Gyu, et al.
Publicado: (2019)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Cabrera, Daniel, et al.
Publicado: (2017)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019)

Glucosinolates Extracts from Brassica juncea Ameliorate HFD-Induced Non-Alcoholic Steatohepatitis
por: Sheu, Ming-Jen, et al.
Publicado: (2023)

Disruption of the Non-Canonical WNT Pathway in Lung Squamous Cell Carcinoma
por: Lee, Eric H.L., et al.
Publicado: (2008)

Gsdma3 regulates hair follicle differentiation via Wnt5a-mediated non-canonical Wnt signaling pathway
por: He, Long, et al.
Publicado: (2017)

Wnt9 directs zebrafish heart tube assembly via a combination of canonical and non-canonical pathway signaling
por: Paolini, Alessio, et al.
Publicado: (2023)

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
por: Xu, Zheng-Jie, et al.
Publicado: (2009)

Discrete roles of canonical and non-canonical Wnt signaling in hematopoiesis and lymphopoiesis
por: Famili, F, et al.
Publicado: (2015)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Macrophages Mediate a Switch between Canonical and Non-Canonical Wnt Pathways in Canine Mammary Tumors
por: Król, Magdalena, et al.
Publicado: (2014)

Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway
por: Liu, Yayun, et al.
Publicado: (2019)

Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis
por: Xu, Lianjie, et al.
Publicado: (2022)

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Amelioration of Non-Alcoholic Steatohepatitis by Atractylodes macrocephala Polysaccharide, Chlorogenic Acid, and Geniposide Combination Is Associated With Reducing Endotoxin Gut Leakage
por: Leng, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8gv6ifqpugv4h9mdb8o44efma